# FDA Inspection 783103 - Saving Sight - May 16, 2012

Source: https://www.keypedia.com/records/fda_inspections/saving-sight/c6f6ae6c-3fb2-4537-adb2-cc787f558421
Source feed: FDA_Inspections

> FDA Inspection 783103 for Saving Sight on May 16, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 783103
- Company Name: Saving Sight
- Inspection Date: 2012-05-16
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 970160 - 2016-05-10](https://www.keypedia.com/records/fda_inspections/saving-sight/7b61cdca-6f66-44f7-9847-daed5c6def92)
- [FDA Inspection 861664 - 2014-01-02](https://www.keypedia.com/records/fda_inspections/saving-sight/a2808128-f129-47ae-b323-a9a725504585)

Company: https://www.keypedia.com/companies/saving-sight/20865229-ee2c-49d8-b8cf-01a1528b5460

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d